InsightRX presents at the BIO Investor Forum

October 18, 2018

InsightRX, a leader in developing and implementing digital therapeutics which augment medicine at the point of care, presented at the 17th annual BIO Investor Forum in San Francisco, CA on October 17th - 18th. The forum assembled a select group of top and emerging startups in biotech and healthcare, along with leading public and private equity investors to explore the opportunities and trends in the space. Dr. Goswami (CEO of InsightRX) discussed how InsightRX leverages the principles of quantitative pharmacology and machine learning to enable clinicians to individualize dosing at the point of care.

More information about the BIO Investor Forum can be found here.